Ciro Mercurio
IFOM(IT)Istituti di Ricovero e Cura a Carattere Scientifico(IT)European Institute of Oncology(IT)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Histone Deacetylase Inhibitors Research, Cancer-related Molecular Pathways, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research
Most-Cited Works
- → Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer(2011)366 cited
- → Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosis(2000)199 cited
- → Histone deacetylases and epigenetic therapies of hematological malignancies(2010)126 cited
- → Identification of N,1,4,4-Tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide (PHA-848125), a Potent, Orally Available Cyclin Dependent Kinase Inhibitor(2009)126 cited
- → Toward Highly Potent Cancer Agents by Modulating the C-2 Group of the Arylthioindole Class of Tubulin Polymerization Inhibitors(2012)120 cited
- → Cyclin-Dependent Kinase 2 Functions in Normal DNA Repair and Is a Therapeutic Target in BRCA1-Deficient Cancers(2006)